knowledge landing page image

KWM advises on Sino Biopharmaceutical’s €750 million convertible bonds

News - Hong Kong

KWM advises on Sino Biopharmaceutical Limited’s €750 million convertible bonds

We are pleased to have advised Sino Biopharmaceutical on its first-time issuance of €750 million zero coupon convertible bonds due 2025.

19 February 2020

KWM Hong Kong strengthens capital markets capabilities with the addition of Jason Kuo

We are pleased to announce the continued expansion of our capital markets practice with the addition of Jason T. Kuo.

17 February 2020

KWM continues to climb global brand index

KWM has risen in the rankings of the world’s best legal brands, jumping two places to 14th in the 2020 Acritas Global Elite Law Firm Brand Index.

24 January 2020

KWM leads in Chambers FinTech 2020 rankings

We are pleased to have maintained our leading position as a Band 1 law firm in Chambers FinTech 2020 rankings.

23 January 2020

KWM advises on SANVO Fine Chemicals Group Limited’s Hong Kong IPO

We advised on SANVO Fine Chemicals’ Hong Kong IPO.

16 January 2020

KWM advises on Poly Property Development’s HK$4.68 billion H-share IPO

We advised Poly Property on its HK$4.68 billion IPO and H-share listing on SEHK.

19 December 2019

This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

For more information on which cookies we use then please refer to our Cookie Policy.